Action for A-T is a medical research charity committed to funding high quality research projects that have the potential to advance our understanding of A-T and lead to treatments and cures. A-T (ataxia-telangiectasia) is a rare, genetic degenerative disease of childhood, which affects multiple systems of the human body. The charity is exclusively dedicated to funding scientific and medical research into A-T; as well as working to drive research and awareness of the condition. Action for A-T was established in 2012 to increase investment into A-T research in the UK and aims to make a difference to the lives of those affected by the condition.
Action Medical Research is a UK-wide charity funding vital research to help sick and disabled babies, children and young people. For over 60 years we’ve been saving and changing lives through medical research. Our peer review system and Scientific Advisory Panel finds and funds cutting-edge medical research in the UK most likely to deliver real benefit to babies, children and young people. Through funding projects grants and research training fellowships we tackle premature birth and treat sick and vulnerable babies, help children affected by disability, disabling conditions and infections and target rare diseases that together severely affect many forgotten children.
Our vision is of a world where deafness, hearing loss and tinnitus do not limit or label people and where people value their hearing. Our work is focussed on achieving the following outcomes: Everyone has the right information, advice, care and support; There is a range of equipment, treatments and cures available; Equality and life choices are not limited. As the only charity in the UK dedicated to funding research into hearing loss and tinnitus, we are increasing capacity for hearing research, making scientific discoveries that will lead to treatments and cures, and supporting translational research to turn promising discoveries into treatments.
We are a lead funder of high quality research into the causes, impact and prevention of alcohol-related harm and are the only organisation exclusively dedicated to building an evidence base in this area. We identify gaps in the evidence base and fund new research and projects that will help to fill them. Most of the grants that we make are funded from the income generated by our endowment but we also act as a conduit for, or work in partnership with, other individuals and organisations that wish to invest in research into alcohol-related harm.
Alzheimer's Society is the largest care and research charity in the UK. We fund research into the cause, cure, care and prevention of all forms of dementia to improve treatment for people today, and search for a cure for tomorrow. All research is carried our for the benefit of patients, and we put people affected by dementia at the heart of our grant funding programme.
Alzheimer’s Research UK is the UK’s leading dementia research charity specialising in finding preventions, causes, treatments and a cure for dementia. We believe that science and innovation hold the key to defeating dementia. We conduct world-class research, we help people to understand dementia and the progress we are making, and we forge partnerships with Government and other key organisations to make dementia research a national priority.
Anthony Nolan was established with the purpose of achieving the following charitable objectives: 1. To provide relief, treatment or cures for people with blood cancer* 2. To provide information to help people with blood cancer 3. To carry out research into the causes, diagnosis and treatment of blood cancer 4. To advance research into improving blood stem cell transplantation and to publish the useful results of such research *or similar immunological deficiencies, diseases or conditions
Antibiotic Research UK (ANTRUK) is a charity dedicated to finding new antibiotics against resistant bacteria, educating the public and professionals about AMR and providing patient information. The goals of the charity are to protect and promote the health of the public by sponsoring research into the diagnosis, treatment and cure of antibiotic-resistant bacterial infectious diseases, ensuring responsible and sustainable development and deployment of the findings of such research, and raising awareness through public-facing activities and the promotion of networks to share experience of such matters.
Arthritis Research UK supports research into the cause, treatment and cure of arthritis and musculoskeletal diseases. The research of the charity encompasses a broad range of research areas, including molecular and cellular biology, immunology and inflammation research, pain, biomechanics and bioengineering, preventative medicine, orthopaedics, genetics and epidemiology and regenerative medicine. The research of the charity also has a focus on the translational and exploitation and supports experimental medicine and clinical trials. The charity has significant policy activity and leads on the promotion of musculoskeletal health by informing and educating health professionals and those affected by musculoskeletal conditions.
Asthma UK is the national charity dedicated to asthma in the UK and has a responsibility to tackle the issues affecting people with asthma today, and conduct research that will lead to a better future for people affected by asthma tomorrow. Whilst asthma kills three people each day, research into asthma is under-resourced and under-funded. Under the charity’s current research strategy, Asthma UK funds research into understanding the causes of asthma, stopping fatal asthma attacks, developing new and better treatments, encouraging good asthma control and preventing and curing asthma. To date, the charity has spent over £50 million on research.
Ataxia UK aims to find treatments and a cure for people with ataxia, a group of neurological conditions. Specifically the charity will fund research of relevance to people with ataxia and in which the ataxia is likely to be progressive. This includes conditions such as Friedreich’s ataxia, the spinocerebellar ataxias and other cerebellar ataxias (including idiopathic ones).
The A-T Society funds and promotes research to find better treatments and ultimately a 'cure' for Ataxia-Telangiectasia. We have funded basic research, clinical trials, research posts, equipment and specialist A-T conferences. Much valuable research is currently being done into the bio-chemistry of the ATM protein. We therefore focus on research to improve or develop new treatments. A-T research is also held back by the condition’s rarity and consequent scarcity of researchers, and the range of systems it affects. We therefore focus on developing the A-T research capability in the UK and on building co-operation and partnerships in A-T research.
Autistica funds medical research to understand the causes of autism, improve diagnosis, and develop new treatments and interventions. We are the UK's leading autism medical research charity, and we are committed to funding translational research that will make a difference to people's lives.
We are a UK based Research Charity with our own laboratories and scientific and administrative staff. Using state-of-the-art bioengineering, molecular and developmental biology techniques our scientists are working on a range of projects. These include investigating ways to improve treatment of severe burns and reduce scarring, including keloid scarring, contracture, soft tissue injury and also research into skin cancers such as melanoma. This programme of research aims to improve the lives of paediatric burns patients, adult burns patients, those suffering from tissue loss due to trauma and patients with melanoma.
Bloodwise is the UK’s biggest blood cancer charity dedicated to improving the lives of patients. Our life-saving work is focused on stopping people from dying of blood cancer, improving the quality of life for patients and their families, and where possible, stopping people getting blood cancer in the first place. We do this by funding world-leading research, providing support for patients and their families, and campaigning for improvements for patients at all stages. Our research is targeted at understanding more about blood cancer, finding causes, and discovering new and improved ways of diagnosing and treating all blood cancers. We support scientists at all stages from PhD and beyond, award a variety of grants for basic and translational research, and run ground-breaking clinical trials to test novel treatments.
Bowel & Cancer Research makes grants across the UK to support medical research into bowel cancer and other chronic bowel conditions. It supports early stage work through a small grants programme intended to help researchers generate high quality data for major funding bids and encourages the next generation of scientific researchers via a PhD studentship programme. It focuses its grant making to improve the diagnosis, treatment and management of bowel cancer and other chronic bowel diseases.
BRACE funds scientific research into the causes, diagnosis and treatment of dementia at universities in South West England and South Wales. It has funded dementia research since 1987, investing millions of pounds to support multidisciplinary research into all aspects of dementia.
We fund research into neurological conditions at UCL Institute of Neurology, Queen Square, London - one of the world’s leading neurological research centres. Our research strategy has seven themes, namely, Alzheimer’s disease and other dementias, brain tumours, epilepsy, multiple sclerosis and other immune-mediated conditions, movement disorders including Parkinson’s disease, stroke and other forms of brain damage and neuro-muscular disorders.